case_images: PMC10264131_01
case_images: ICU treatment summary. d/c: discontinued; ICU: intensive care unit.
case_images: CRICC2023-2000781.001.jpg
case_images: PMC10264131_01_CRICC2023-2000781.001.jpg
case_images: fig1
case_images: Supportive treatment (fluid resuscitation, antibiotic therapy, mechanical ventilation, norepinephrine, and dobutamine) was initiated and adapted from the surviving sepsis campaign-2016 guideline (shown in Figure 1).
case_images: Changes in clinical and biochemical data before and after treatment with the oXiris  membrane. Body temperature, vasopressors doses, PCT, CRP, and IL-6 levels related to the use of the oXiris  membrane. CRP: C reaction protein; PCT: procalcitonin.
case_images: CRICC2023-2000781.002.jpg
case_images: PMC10264131_01_CRICC2023-2000781.002.jpg
case_images: fig2
case_images: The inflammatory biomarkers and doses of vasopressors rapidly declined (shown in Figure 2 and Table 2).